#1 Clinical Trials Search in Europe

Cardiac sarcoidosis – Diagnostics

Go back

Cardiac sarcoidosis is a challenging condition to diagnose because many patients feel no symptoms at all, and when symptoms do appear, they can mimic many other heart problems. Understanding when testing is needed and what tests are available can help you and your doctor catch this condition early, before permanent damage occurs.

Introduction: Who Should Undergo Diagnostics

Deciding who needs testing for cardiac sarcoidosis is not always straightforward. This condition can hide silently in your heart for months or even years without causing any noticeable problems. However, certain groups of people should consider getting their heart checked even if they feel perfectly fine.[1]

If you have already been diagnosed with sarcoidosis in another part of your body—such as your lungs, eyes, skin, or lymph nodes—your doctor may want to screen your heart for involvement. Experts believe that up to one in four people with sarcoidosis elsewhere in the body actually have granulomas (clumps of immune cells) in their heart, even without symptoms.[1] This means that having sarcoidosis in your lungs or other organs automatically puts you at higher risk, and screening can help detect heart problems before they become serious.

You should also seek diagnostic testing if you experience certain symptoms that suggest your heart may be affected. These warning signs include chest pain or tightness, heart palpitations (feeling like your heart is racing or skipping beats), fainting or feeling like you might pass out, unusual fatigue that doesn’t go away with rest, shortness of breath, persistent coughing, dizziness, or swelling in your legs.[1][5] Any of these symptoms deserve prompt medical attention, because they may signal that inflammation or scarring is disrupting your heart’s normal function.

People with a family history of cardiac sarcoidosis also face higher risk. If someone in your biological family has been diagnosed with this condition, your genes may make your immune system more likely to form granulomas in your heart. In such cases, discussing screening with your doctor makes sense, especially if you develop any unusual symptoms.[1]

It’s important to understand that cardiac sarcoidosis can mimic many other heart conditions. Someone experiencing chest pain or irregular heartbeat might think they’re having a heart attack or developing another type of heart disease. This similarity to other conditions makes it especially important to seek evaluation from heart doctors who understand cardiac sarcoidosis and know how to distinguish it from other problems.[3]

⚠️ Important
Many people with cardiac sarcoidosis have no symptoms at all. The granulomas may form in areas of the heart that don’t immediately affect its function, or the inflammation may be mild enough that you don’t notice anything wrong. This is why screening is so important for people already diagnosed with sarcoidosis in other organs. Early diagnosis gives you the best chance to manage symptoms and protect your heart before permanent scarring develops.

Diagnostic Methods

Diagnosing cardiac sarcoidosis requires multiple steps and often several different tests, because there is no single test that can definitively confirm or rule out the condition. Your doctor will use a combination of physical examination, medical history, and various diagnostic tools to piece together the full picture of what’s happening in your heart.[2]

Physical Examination and Medical History

The diagnostic journey typically begins with a thorough physical exam. Your healthcare provider will listen to your heart and lungs using a stethoscope, checking for abnormal sounds that might indicate problems with heart function or fluid buildup. They will also check your lymph nodes for swelling, examine any skin lesions, and look at your overall appearance for signs of illness.[1]

Your doctor will ask detailed questions about your symptoms—when they started, how often they occur, what makes them better or worse, and whether they’re getting progressively worse over time. They will also want to know about your family health history, particularly whether any blood relatives have been diagnosed with sarcoidosis. Environmental exposure questions may come up too, such as whether you’ve been exposed to mold, bacteria, viruses, pesticides, fumes, or other potential triggers that experts believe might activate the immune system in susceptible people.[3]

Blood Tests

Blood tests cannot directly diagnose cardiac sarcoidosis, but they provide valuable information about how your body is functioning. These tests can reveal signs of inflammation throughout your body and check how well your organs are working. Blood work helps doctors rule out other conditions that might cause similar symptoms and can show whether sarcoidosis is affecting other organs besides your heart.[1]

Chest X-Ray

A chest X-ray creates a picture of your heart, lungs, and surrounding structures. Since most people with sarcoidosis have lung involvement, a chest X-ray can often show granulomas or enlarged lymph nodes in the chest. While it may not reveal cardiac sarcoidosis directly, it can provide clues about whether sarcoidosis is present in your body and suggest the need for more detailed heart-specific testing.[1]

Electrocardiogram (EKG)

An electrocardiogram, often shortened to EKG or ECG, measures the electrical activity of your heart. Small sticky patches called electrodes are placed on your chest, arms, and legs, and they pick up the electrical signals that make your heart beat. This painless test takes only a few minutes and can reveal abnormal heart rhythms, heart block (when electrical signals are delayed or blocked), or signs that parts of your heart muscle aren’t working properly. These findings might suggest that granulomas or scarring are interfering with your heart’s electrical system.[1]

Holter Monitor

A Holter monitor is a portable device that you wear for 24 to 48 hours (or sometimes longer) while going about your normal daily activities. It continuously records your heart’s electrical activity, capturing any irregular rhythms that might come and go throughout the day and night. This extended monitoring can catch problems that might not show up during a brief office visit. Since cardiac sarcoidosis can cause dangerous heart rhythms that come and go unpredictably, this type of monitoring provides crucial information.[1]

Echocardiogram

An echocardiogram uses sound waves to create moving pictures of your heart. A technician moves a device called a transducer across your chest, and it sends sound waves that bounce off your heart structures and return to create images on a screen. This test shows how well your heart chambers are pumping blood, how your heart valves are working, and whether there are any abnormal areas in the heart muscle. Doctors can see if parts of the heart wall aren’t moving properly, which might indicate damage from granulomas or scarring.[1]

Cardiac MRI

A cardiac MRI (magnetic resonance imaging) is one of the most valuable tests for detecting cardiac sarcoidosis. This test uses powerful magnets and radio waves to create highly detailed images of your heart’s structure. Unlike X-rays, MRI doesn’t use radiation. During the test, you lie inside a large tube-shaped machine for about 30 to 60 minutes while it takes pictures from multiple angles.[1]

Cardiac MRI is particularly good at showing both active inflammation and old scars in the heart muscle. The test can detect late gadolinium enhancement, which is a pattern that shows up when scarring is present. It can also reveal edema (swelling) that indicates active, ongoing inflammation. This information helps doctors understand how far the disease has progressed and whether the inflammation is still active or if only old scarring remains.[5]

PET Scan

A PET scan (positron emission tomography) is a type of nuclear imaging study that can detect active inflammation in the heart. Before the scan, you receive an injection of a small amount of radioactive material, which travels through your bloodstream and accumulates in areas where there is active inflammation. Special cameras then detect this radioactive material and create images showing “hot spots” where inflammation is occurring.[1]

PET scans are especially valuable because they show where inflammation is actively happening right now, not just where old scars exist. This helps doctors decide whether you need treatment to reduce inflammation and can also help them monitor whether treatment is working. When used together with cardiac MRI, PET scans provide a comprehensive picture of both active inflammation and scarring.[5]

Heart Biopsy

An endomyocardial biopsy involves taking a small sample of heart tissue to examine under a microscope. While this is the most accurate way to diagnose cardiac sarcoidosis by directly seeing granulomas, doctors usually don’t use it as a first choice. The procedure is invasive—it requires threading a catheter through a blood vessel into the heart to remove tiny pieces of tissue. More importantly, cardiac sarcoidosis causes granulomas to form in scattered, patchy areas throughout the heart, so the biopsy needle might miss affected areas even when the disease is present. Because of this low sensitivity and the invasive nature of the procedure, doctors typically rely on the combination of other tests instead.[1][2]

The most accurate diagnosis comes from finding granulomas in heart tissue during biopsy, but because of the practical limitations, doctors often diagnose cardiac sarcoidosis through a combination approach. They look for evidence of sarcoidosis in other organs (confirmed by biopsy of more accessible tissue like skin or lymph nodes), plus clinical symptoms that suggest heart involvement, plus imaging studies showing patterns consistent with cardiac sarcoidosis. This combination approach allows diagnosis without the risks and limitations of heart biopsy.[5]

Testing to Rule Out Other Conditions

Because cardiac sarcoidosis can mimic many other heart problems, an important part of diagnosis involves ruling out other conditions. Your doctor may order additional tests to exclude heart attacks, other types of cardiomyopathy (heart muscle disease), heart valve problems, or coronary artery disease. This is why diagnosis is often challenging and requires expertise from doctors who specialize in cardiac sarcoidosis and understand how to distinguish it from similar conditions.[2][3]

Staging and Assessing Disease Progression

There is no single, universally accepted staging system for cardiac sarcoidosis. However, doctors may describe the condition in terms of how much damage they see. Early-stage disease involves mainly inflammation without much permanent scarring. At this stage, treatment may be able to reverse the damage. Advanced-stage disease involves significant scarring of the heart muscle, which is permanent and cannot be reversed, though treatment can still help manage symptoms and prevent further damage.[1]

Imaging studies, particularly cardiac MRI, help doctors understand how far the condition has progressed. Seeing mostly inflammation with little scarring suggests earlier disease that may respond better to treatment. Finding extensive scarring indicates that the condition has been present for a longer time and has caused permanent changes to the heart structure.[1]

⚠️ Important
Cardiac sarcoidosis is sometimes considered a diagnosis of exclusion because there is no single test that can definitively prove you have it. Doctors must carefully evaluate multiple pieces of evidence—your symptoms, test results, and whether other conditions have been ruled out. This process requires patience and often involves seeing multiple specialists. If you have unexplained heart symptoms or known sarcoidosis elsewhere in your body, don’t hesitate to ask your doctor about comprehensive cardiac evaluation, even if initial tests seem normal.

Diagnostics for Clinical Trial Qualification

When patients with cardiac sarcoidosis are being considered for enrollment in clinical trials, they typically undergo additional standardized testing beyond what’s needed for routine diagnosis. Clinical trials require precise documentation of the disease to ensure that all participants meet specific criteria and to measure whether investigational treatments are working.

Clinical trials for cardiac sarcoidosis generally require confirmation that patients actually have the condition through accepted diagnostic criteria. This usually means demonstrating evidence of sarcoidosis somewhere in the body (often through biopsy of accessible tissue like lymph nodes, skin, or lung tissue) combined with imaging evidence of heart involvement. Cardiac MRI and PET scans are often mandatory for trial participation because they provide objective, measurable evidence of inflammation and scarring that can be tracked over time.[2]

Trials commonly require baseline measurements of heart function before any experimental treatment begins. This typically includes an echocardiogram to measure left ventricular ejection fraction—a number that tells doctors what percentage of blood the heart pumps out with each beat. This measurement is particularly important because it’s one of the most significant predictors of outcomes in cardiac sarcoidosis. Patients with lower ejection fractions have more severe disease and may be at higher risk for complications.[2]

Electrical testing of the heart is also standard for trial enrollment. An EKG provides baseline information about heart rhythm and conduction. Some trials may require Holter monitoring to document any rhythm abnormalities over an extended period. These tests help researchers understand whether the heart’s electrical system is affected and can be used later to see if treatment improves electrical function.

Blood tests measuring inflammation markers may be required as baseline measurements. While these cannot diagnose cardiac sarcoidosis, they can help track whether inflammation in the body is decreasing with treatment. Kidney and liver function tests are often mandatory before starting any experimental medication to ensure these organs can safely process the drugs being studied.

Some clinical trials specifically study how well certain imaging techniques can track disease progression or response to treatment. In these studies, patients may undergo serial PET scans or MRIs at specific time intervals. The imaging shows whether areas of active inflammation are shrinking with treatment or whether new areas of damage are developing. This objective data helps researchers determine whether an experimental treatment is actually working.

Lung function testing may also be required for trial participation, especially since most people with cardiac sarcoidosis also have lung involvement. These tests measure how much air you can breathe in and out and how efficiently your lungs transfer oxygen to your blood. Documenting lung function helps researchers understand the full extent of sarcoidosis throughout the body and whether treatments affect multiple organ systems.

Clinical trials have strict inclusion and exclusion criteria, which means not everyone with cardiac sarcoidosis will qualify. Some trials only accept patients with newly diagnosed disease, while others focus on people who haven’t responded to standard treatments. Some require that patients have active inflammation visible on PET scan, excluding those with only old scarring. Understanding these criteria helps patients and doctors identify which trials might be appropriate options.

Prognosis and Survival Rate

Prognosis

Cardiac sarcoidosis is described as a rare condition with a generally poor prognosis, though outcomes vary significantly from person to person. The most important factor affecting prognosis is the left ventricular ejection fraction—the measurement of how much blood your heart pumps with each beat. Patients whose hearts pump less effectively face higher risks of complications and poorer outcomes.[2]

Several factors influence how the disease will progress. Early diagnosis and treatment significantly improve the chances of better outcomes. When doctors catch cardiac sarcoidosis before extensive scarring develops, anti-inflammatory treatments may reverse much of the damage and prevent further harm. However, once significant scarring has formed in the heart muscle, this damage is permanent and cannot be undone, though treatment can still prevent additional scarring and help manage symptoms.[2]

Without treatment, cardiac sarcoidosis can lead to life-threatening complications. The inflammation and scarring can cause dangerous heart rhythms, including ventricular tachycardia and ventricular fibrillation, which can result in sudden cardiac death. The disease can also lead to heart failure when the damaged heart muscle cannot pump enough blood to meet the body’s needs. Heart block, where electrical signals are delayed or completely blocked, is another serious complication that may require a pacemaker.[1]

Some patients experience a more favorable course. The disease may remain stable for long periods, or symptoms may even go away on their own in some cases, similar to sarcoidosis in other organs. However, approximately 5 to 10 percent of all patients with sarcoidosis will suffer from advanced disease that causes significant long-term health problems. Patients with isolated cardiac sarcoidosis (affecting only the heart and no other organs) represent about 25 percent of all cardiac sarcoidosis cases.[2]

Survival Rate

Specific survival statistics for cardiac sarcoidosis are not provided in the available sources. However, the sources consistently describe it as a condition with a poor prognosis, emphasizing that early diagnosis and intervention can improve outcomes for patients with this uncommon infiltrative cardiomyopathy.[2] The absence of specific survival percentages reflects the rarity of the condition and the variability in how it affects different individuals.

Ongoing Clinical Trials on Cardiac sarcoidosis

  • Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

References

https://my.clevelandclinic.org/health/diseases/23485-cardiac-sarcoidosis

https://www.ncbi.nlm.nih.gov/books/NBK578192/

https://www.mayoclinic.org/departments-centers/cardiac-sarcoidosis-clinic/overview/ovc-20508707

https://www.ottawaheart.ca/heart-condition/cardiac-sarcoidosis

https://www.columbiacardiology.org/patient-care/center-advanced-cardiac-care-heart-failure-lvad-transplant/conditions-and-treatments/cardiac-sarcoidosis

More information about
Cardiac sarcoidosis:

FAQ

Can cardiac sarcoidosis be diagnosed with just one test?

No, there is no single test that can definitively diagnose cardiac sarcoidosis. Doctors must use a combination of physical examination, medical history, blood tests, imaging studies like cardiac MRI and PET scans, and sometimes evidence of sarcoidosis in other organs to make the diagnosis. This comprehensive approach is necessary because the disease can look like many other heart conditions.

Why don’t doctors routinely use heart biopsies to diagnose cardiac sarcoidosis?

While heart biopsy is highly specific when it finds granulomas, it has very low sensitivity because cardiac sarcoidosis causes patchy inflammation scattered throughout the heart. The biopsy needle might miss affected areas completely. Additionally, the procedure is invasive and carries risks. Because of these limitations, doctors typically rely on the combination of other tests, imaging studies, and clinical findings to diagnose the condition.

If I have sarcoidosis in my lungs, do I need to get my heart checked even without symptoms?

Yes, screening is often recommended. Experts believe up to 25% of people with sarcoidosis elsewhere in the body also have cardiac involvement, often without any symptoms. Many people with cardiac sarcoidosis feel nothing wrong because the granulomas may form in areas that don’t immediately affect heart function. Early detection before symptoms develop gives the best chance to prevent permanent damage.

What’s the difference between what a cardiac MRI and PET scan show?

A cardiac MRI shows both active inflammation and old scars in the heart muscle, providing detailed structural information about damage. A PET scan specifically highlights areas where active inflammation is happening right now by detecting increased metabolic activity. Together, these tests give doctors a complete picture—MRI shows the overall damage and scarring, while PET scan shows which areas have ongoing, active disease that needs treatment.

What symptoms should make me seek immediate medical attention?

Seek immediate medical care if you experience chest pain or tightness, fainting or feeling like you might pass out, severe shortness of breath, heart palpitations (feeling like your heart is racing or skipping beats), or sudden swelling in your legs. These symptoms could indicate serious complications like dangerous heart rhythms or heart failure that require urgent evaluation and treatment.

🎯 Key takeaways

  • • Up to one in four people with sarcoidosis in their lungs or other organs also have it in their hearts, often without any symptoms at all.
  • • There is no single test that can diagnose cardiac sarcoidosis—doctors need to combine multiple tests, imaging studies, and clinical findings to make an accurate diagnosis.
  • • Heart biopsy, while highly specific, is rarely used because granulomas form in scattered patches throughout the heart, making it easy to miss affected areas.
  • • Cardiac MRI and PET scans work together like a team—MRI shows both old scars and swelling, while PET scan highlights exactly where active inflammation is happening right now.
  • • Early diagnosis matters tremendously because catching the disease before extensive scarring develops gives treatment the best chance to reverse damage and protect your heart.
  • • Cardiac sarcoidosis is a master of disguise, mimicking heart attacks and other common heart problems, which is why specialized expertise is crucial for accurate diagnosis.
  • • Left ventricular ejection fraction—how much blood your heart pumps with each beat—is the most important predictor of outcomes in cardiac sarcoidosis.
  • • Clinical trials require extensive baseline testing including cardiac MRI, PET scans, echocardiograms, and blood work to precisely document disease before any experimental treatment begins.

Connected medications: